Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Solitomab Biosimilar – Anti-CD3E, EpCAM mAb – Research Grade

Isotype:
(scFv-kappa-heavy)-(scFv-heavy-kappa)

$238.00

+ 238 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Solitomab Biosimilar - Anti-CD326;EPCAM and CD3E mAb - Research Grade

Solitomab Biosimilar - Anti-CD3E, EpCAM mAb - Research Grade

Product name Solitomab Biosimilar - Anti-CD3E, EpCAM mAb - Research Grade
Source CAS 1005198-65-1
Species Mus musculus
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Solitomab,MT110,CD3E, EpCAM,anti-CD3E, EpCAM
Reference PX-TA1282
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype (scFv-kappa-heavy)-(scFv-heavy-kappa)
Clonality Monoclonal Antibody
Product name Solitomab Biosimilar - Anti-CD3E, EpCAM mAb - Research Grade
Source CAS 1005198-65-1
Species Mus musculus
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Solitomab,MT110,CD3E, EpCAM,anti-CD3E, EpCAM
Reference PX-TA1282
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype (scFv-kappa-heavy)-(scFv-heavy-kappa)
Clonality Monoclonal Antibody

Solitomab Antibody Biosimilar – Anti-CD3E/EpCAM Bispecific Antibody

Solitomab is a bispecific antibody targeting CD3E and EpCAM, designed to redirect T-cells toward EpCAM-expressing tumor cells. This Solitomab biosimilar antibody is produced for research applications requiring reliable binding activity and high purity.

Our research grade Solitomab antibody enables scientists to investigate T-cell mediated cytotoxicity, tumor immunology, and bispecific antibody mechanisms in preclinical studies.

This antibody is widely used in research involving EpCAM-positive tumor models, immune cell activation assays, and bispecific antibody development.

Key Features

  • Solitomab biosimilar antibody
  • Anti-CD3E / EpCAM bispecific antibody
  • Research grade quality
  • High purity and reproducibility
  • Suitable for immuno-oncology research
  • Competitive Solitomab antibody price

Applications

This Solitomab antibody biosimilar is suitable for multiple research applications including:

  • T-cell engagement assays
  • EpCAM-targeted immunotherapy research
  • Tumor immunology studies
  • Bispecific antibody development
  • Cancer cell targeting studies

For research use only.

Solitomab Antibody Price

For bulk quantities or custom production, request a custom Solitomab antibody quote.

Why Order Solitomab Biosimilar from Proteogenix

Reliable biosimilar antibody production
Competitive Solitomab antibody pricing
Fast international shipping
Quality-controlled research reagents
Trusted supplier for biotech and academic labs

SDS-PAGE for Solitomab Biosimilar - Anti-CD326;EPCAM and CD3E mAb - Research Grade

SDS-PAGE for Solitomab Biosimilar - Anti-CD326;EPCAM and CD3E mAb - Research Grade

Solitomab Biosimilar - Anti-CD326;EPCAM and CD3E mAb - Research Grade on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue.. The purity of the antibody is greater than 95%.

  • Enhanced anti-tumor activity by Zinc Finger Repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs, Marion David, Phillip Schiele, Davide Monteferrario, Gaëlle Saviane, Angélique E. Martelli, Coralie F. Dupont, Caroline Jeanneau, Irène Marchetti, Satish K. Tadi, Julia Vahldick, Lynn N. Truong, Yuanyue Zhou, Igor M. Sauer, Wenzel Schöning, Il-Kang Na, Andreas Reik, Marco Frentsch, Maurus de la Rosa, David Fenard, bioRxiv 2024.10.11.613893; doi: https://doi.org/10.1101/2024.10.11.613893

  • Vele — April 6, 2022

    Great product!

Add a review

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products